The impact of patient and public involvement on COVID-19 immunology research: experiences from the UK Coronavirus Immunology Consortium

Erika Neves Aquino,Paul Moss,Mo Hafeez,Robert Jasper,Tony Kelly,Lynn Laidlaw,Vivienne Wilkes
DOI: https://doi.org/10.1186/s40900-023-00446-1
2023-05-23
Research Involvement and Engagement
Abstract:Patient and Public Involvement (PPI) in clinical trial research is recognised as relevant but the active involvement of patients and the public in basic science or laboratory-based research is seen as more challenging and not often reported. PPI within the UK Coronavirus Immunology Consortium (UK-CIC), a translational research project aimed at tackling some of the key questions about the immune system's response to SARS-CoV-2, is an example of overcoming negative perceptions and obstacles. Given the widespread impact of COVID-19, it was important to consider the impact of UK-CIC research on patients and the public throughout, and the PPI panel were an integral part of the consortium.
What problem does this paper attempt to address?